Annually, RIVM publishes an overview of surveillance data and scientific developments of the 13 infectious diseases against which the Dutch National Immunisation Programme (RVP in Dutch) vaccinates. The report on Surveillance and Developments also contains information about infectious diseases that are not (yet) included in the National Immunisation Programme, but for which a vaccine is available, such as chickenpox and shingles. 

In 2022, the percentage of children vaccinated within the Dutch National Immunisation Programme (NIP) has fallen for the second year in a row. Registered vaccination coverage is about 2% to 5% lower than in 2021, according to the 2022 annual report. Measles vaccination coverage for babies appears to be just below 90% for the first time in years. Vaccination coverage above 95% is important to protect all residents of the Netherlands against this disease. If that rate is not achieved, measles is more likely to resurface.

Concerned about this decline, RIVM is investigating how vaccination coverage can be improved.

Read more in  the report Vaccination coverage and annual report of the National Immunisation Programme in the Netherlands, 2022 or news item Concerns over falling vaccination coverage within National Immunisation Programme